Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated plasma total homocysteine (tHcy) is associated with the development of Alzheimer's disease and other forms of dementia. In this study, we report the relationship between tHcy and epigenetic age in older adults with mild cognitive impairment from the VITACOG study. Epigenetic age and ra...

Detaylı Bibliyografya
Asıl Yazarlar:	Holmes, HE, Valentin, RE, Jernerén, F, de Jager Loots, CA, Refsum, H, Smith, AD, Guarente, L, Dellinger, RW, Sampson, D, Alzheimer's Disease Neuroimaging Initiative
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Wiley Open Access 2024

Benzer Materyaller

Random forest prediction of Alzheimer's disease using pairwise selection from time series data
Yazar:: Moore, P, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Two for tau: automated model discovery reveals two-stage tau aggregation dynamics in Alzheimer’s disease
Yazar:: Stockman, CA, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
Yazar:: Oulhaj, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
Yazar:: de Jager, C, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
Yazar:: De Jager, C, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Quantifying uncertainty in brain-predicted age using scalar-on-image quantile regression
Yazar:: Palma, M, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome.
Yazar:: Jones, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
Yazar:: Smith, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
Yazar:: Smith, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
Yazar:: Smith, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Homocysteine, B vitamins, and cognitive impairment
Yazar:: Smith, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Homocysteine, B vitamins, and cardiovascular disease
Yazar:: Refsum, H, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
Yazar:: Refsum, H, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
Yazar:: Nurk, E, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
Yazar:: De Jager, C, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Disrupted network topology in patients with stable and progressive mild cognitive impairment and Alzheimer's disease
Yazar:: Pereira, J, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Morphometricity as a measure of the neuroanatomical signature of a trait
Yazar:: Ge, Tian, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
Yazar:: Nho, K, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Generalized reduced rank latent factor regression for high dimensional tensor fields, and neuroimaging-genetic applications
Yazar:: Tao, C, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Accelerating permutation testing in voxel-wise analysis through subspace tracking: A new plugin for SnPM
Yazar:: Gutierrez-Barragan, F, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Elevated plasma total homocysteine increased the risk of dementia in the elderly: Commentary
Yazar:: Sheehan, B, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Elevated plasma total homocysteine levels increased the risk for dementia in the elderly.
Yazar:: Sheehan, B, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease
Yazar:: Refsum, H, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Homocysteine and dementia – an international consensus statement
Yazar:: Smith, DA, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
Yazar:: Oulhaj, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Yazar:: Oulhaj, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Facts and recommendations about total homocysteine determinations: an expert opinion
Yazar:: Refsum, H, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Effects of S-adenosyl-L-homocysteine and trichostatin A on developmental competence, epigenetic modification, and gene expression in cloned cattle embryos
Yazar:: Jafari, Shahram
Baskı/Yayın Bilgisi: (2012)

Variability and determinants of total homocysteine concentrations in plasma in an elderly population.
Yazar:: Clarke, R, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
Yazar:: Clarke, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
Yazar:: Clarke, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Sirt3 deficiency does not affect venous thrombosis or NETosis despite mild elevation of intracellular ROS in platelets and neutrophils in mice
Yazar:: Hayashi, Hideki, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study.
Yazar:: Halsted, C, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
Yazar:: Clarke, R, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels.
Yazar:: Tunbridge, E, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Facts and recommendations about total homocysteine determinations: an expert opinion.
Yazar:: Refsum, H, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Cysteine, homocysteine and bone mineral density: a role for body composition?
Yazar:: Elshorbagy, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
Yazar:: Clarke, R, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people.
Yazar:: Budge, M, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Human plasma homocysteine levels are associated with the catechol-O-methyltransferase Val158Met polymorphism
Yazar:: Tunbridge, E, ve diğerleri
Baskı/Yayın Bilgisi: (2007)